Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Sale | 2024-11-20 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 5,360 | $4.08 | $21,869 | 284,685 (Direct) | View |
| 2024-05-20 Sale | 2024-05-22 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 22,725 | $6.45 | $146,576 | 288,031 (Direct) | View |
| 2024-02-12 Sale | 2024-02-14 8:42 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 9,846 | $15.24 | $150,053 | 306,292 (Direct) | View |
| 2023-11-20 Sale | 2023-11-22 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 3,287 | $9.69 | $31,851 | 217,374 (Direct) | View |
| 2023-05-22 Sale | 2023-05-24 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 6,305 | $10.12 | $63,807 | 219,327 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 6:17 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 3,573 | $11.36 | $40,586 | 151,396 (Direct) | View |
| 2022-11-21 Sale | 2022-11-23 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 3,335 | $11.56 | $38,553 | 154,213 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 37,120 | $0 | 310,756 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:42 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 97,968 | $0 | 306,292 (Direct) | View |
| 2023-03-08 Option Award | 2023-03-10 5:07 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 111,354 | $0 | 262,750 (Direct) | View |
Ownership | 2022-06-08 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 0 | $0 | 156,516 (Direct) | View |